---
pmid: '24681097'
title: AROS has a context-dependent effect on SIRT1.
authors:
- Kokkola T
- Suuronen T
- Molnár F
- Määttä J
- Salminen A
- Jarho EM
- Lahtela-Kakkonen M
journal: FEBS Lett
year: '2014'
full_text_available: false
doi: 10.1016/j.febslet.2014.03.020
---

# AROS has a context-dependent effect on SIRT1.
**Authors:** Kokkola T, Suuronen T, Molnár F, Määttä J, Salminen A, Jarho EM, Lahtela-Kakkonen M
**Journal:** FEBS Lett (2014)
**DOI:** [10.1016/j.febslet.2014.03.020](https://doi.org/10.1016/j.febslet.2014.03.020)

## Abstract

1. FEBS Lett. 2014 May 2;588(9):1523-8. doi: 10.1016/j.febslet.2014.03.020. Epub 
2014 Mar 26.

AROS has a context-dependent effect on SIRT1.

Kokkola T(1), Suuronen T(2), Molnár F(2), Määttä J(3), Salminen A(4), Jarho 
EM(2), Lahtela-Kakkonen M(2).

Author information:
(1)School of Pharmacy, University of Eastern Finland, Kuopio, Finland. 
Electronic address: tarja.kokkola@uef.fi.
(2)School of Pharmacy, University of Eastern Finland, Kuopio, Finland.
(3)Institute of Biomedical Technology, University of Tampere, Tampere, Finland.
(4)Department of Neurology, University of Eastern Finland, Kuopio, Finland.

The modulation of protein deacetylase SIRT1 has a vast therapeutic potential in 
treatment of several aging-associated diseases. Active regulator of SIRT1 (AROS) 
is a small endogenous protein which was originally reported to activate SIRT1 
through a direct interaction in cancer cells. We show that the interaction 
between the two proteins is weak and does not alter the activity of SIRT1 in 
non-cancerous human cells. The results of different in vitro SIRT1 activity 
assays disclosed AROS as an inhibitor of SIRT1. The functional relationship 
between AROS and SIRT1 proved to be dependent on the biological context and 
experimental setting.

Copyright © 2014 Federation of European Biochemical Societies. Published by 
Elsevier B.V. All rights reserved.

DOI: 10.1016/j.febslet.2014.03.020
PMID: 24681097 [Indexed for MEDLINE]
